Post-approval studies (Phase 4)Study completedNCT00619697
What this trial is testing
Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes
Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 260